Company: ScubaTx Ltd
CEO: David Campbell
Website: https://www.scubatx.com/
About ScubaTx Ltd
ScubaTx was founded in 2020 to tackle one of the most critical challenges in transplantation: the short time available to preserve organs between donation and transplant. Our mission is to redefine how organs are maintained and transported, improving patient outcomes and reducing the number of organs lost due to time constraints.
From the beginning, ScubaTx faced significant hurdles. Developing advanced preservation technology for organs such as the heart and lungs required collaboration between engineers, clinicians, and regulatory specialists. The team overcame technical complexities in hypothermic temperature control and perfusion systems while ensuring compliance with strict medical device standards. Securing funding during early development was another challenge, but ScubaTx successfully attracted support through competitive grants, investor partnerships, and philanthropic contributions. These resources enabled the company to progress from concept to prototype and prepare for regulatory submissions.
One of our most notable achievements has been the development of an advanced hypothermic temperature control device designed for heart preservation. This innovation extends the safe preservation window, giving surgical teams more flexibility and improving patient outcomes. The technology is being expanded to support lung preservation and future capabilities such as persufflation, which could further enhance organ viability.
ScubaTx has made a significant impact on the organ preservation industry. Traditionally, organ transport has relied on static cold storage, a method that has remained largely unchanged for decades. By introducing dynamic temperature control and advanced preservation techniques, ScubaTx is setting a new standard for organ care. This approach not only improves the quality of organs available for transplant but also opens the door to broader geographic sharing, helping more patients receive life-saving procedures.
The company works closely with leading transplant centres and organ procurement organisations to validate its technology in real-world settings. These collaborations ensure that innovations are clinically relevant and deliver measurable benefits. ScubaTx is committed to maintaining the highest quality standards, with plans for CE mark and FDA clearance to support global adoption.
Looking ahead, ScubaTx aims to expand its platform to multiple organ types and integrate data-driven insights to optimize preservation protocols. The ultimate goal is to reduce organ discard rates and improve transplant success worldwide. By combining engineering excellence with clinical expertise, ScubaTx is driving a transformation that will benefit thousands of patients every year.
ScubaTx is proud to be part of a movement that brings innovation to healthcare and saves lives. With a strong foundation, a clear vision, and a commitment to continuous improvement, the company is poised to make a lasting impact on transplantation and beyond.
Check out what TechRound can do for your business: SEO, PR, HR Software, Payroll Software, IT, VoIP.
